Clinically Validated Cranberry Extract (Vaccinium macrocarpon) Standardized in Proanthocyanidins (PACs) for Urinary Tract Health
Urinary Tract Infections (UTIs) represent one of the most frequent bacterial infections globally, disproportionately affecting women (with over 25% experiencing recurrent episodes). The vast majority of UTIs are triggered by uropathogenic Escherichia coli (UPEC) colonizing the uroepithelial lining.
CRAN'BEY® is a high-potency, standardized extract derived from premium North American Vaccinium macrocarpon fruits. Bio-engineered to deliver validated anti-adhesion protection, CRAN'BEY® effectively neutralizes bacterial P-fimbriae, enabling natural bacterial clearance without inducing antibiotic resistance.
Rigorous scientific evaluations confirm that CRAN'BEY® delivers robust anti-adhesion activity against pathogenic E. coli strains in human urine models.
Uropathogenic E. coli rely on hair-like projections called P-fimbriae to lock onto specific carbohydrate receptors on uroepithelial cells. The active Type-A Proanthocyanidins (PACs) contained in CRAN'BEY® bind directly to these bacterial fimbriae. This steric blocking prevents adhesion, rendering the bacteria incapable of colonizing the urinary tract so they can be safely flushed away via normal urination.
Human clinical investigations demonstrate a dose-dependent anti-adhesion effect in urine samples collected following standardized cranberry intake. Ex-vivo bioassays show that urine collected 1-6 hours and 24 hours post-consumption of 36 mg PACs exhibits profound bacterial anti-adhesion properties compared to placebo, significantly extending mean host survival times against bacterial challenge.
1. In-Vivo Model Survival: Infection trials using the Caenorhabditis elegans model demonstrated that host survival time (LT50) increased to 5-6 days when bacteria were exposed to urine collected post-cranberry consumption, compared to only 3 days with placebo urine.
2. Sustained Bioactivity: Statistically significant anti-adhesion inhibition persists in human urine up to 24 hours post-dose, confirming round-the-clock urinary tract protection.
Preserving fragile bioactive polymers requires advanced processing discipline and rigorous analytical controls.
Utilizes ultra-low temperature drying to prevent thermal degradation of delicate A-type proanthocyanidin dimers, maintaining native bioactivity and long-term shelf stability.
Standardized using validated European Pharmacopoeia and BL-DMAC methods to eliminate falsely inflated PAC readings common with unspecific colorimetric assays.
Extracted exclusively from non-GMO North American Vaccinium macrocarpon cultivated in controlled agricultural environments with full farm-to-extract traceability.
Select from multiple active concentrations tailored to match your target unit dosage, galenic format, and cost parameters.
| Commercial Grade | PAC Concentration | Recommended Daily Dose | Primary Formulations |
|---|---|---|---|
| CRAN'BEY® 60 | 60% PACs | 144 mg / day | High-potency compact capsules, micro-tablets |
| CRAN'BEY® 50 | 50% PACs | 196 mg / day | Standard dietary supplement capsules, hardgels |
| CRAN'BEY® 40 | 40% PACs | 240 mg / day | Tablets, effervescent powders, sachet blends |
| CRAN'BEY® 30 | 30% PACs | 309 mg / day | Functional food blends, gummies, stick-packs |
| CRAN'BEY® 25 | 25% PACs | 360 mg / day | Syrups, liquid shots, botanical tea concentrates |
Combine CRAN'BEY® with our synergistic active botanicals and targeted probiotic strains for comprehensive health positioning.
Supports emotional well-being & cognitive balance naturally
Restores emotional equilibrium & promotes restorative sleep
Enhances cognitive performance & executive function
Targeted psychobiotic blend maintaining mental focus under stress
Request technical dossiers, full Certificates of Analysis (COA), sample quantities, or clinical documentation from our expert formulation specialists.
Contact Us